Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x100px
Organisation › Details

AaviGen GmbH

AaviGen was founded in 2019 on the understanding that successful gene therapy requires optimized delivery of therapeutic targets to the diseased heart. AaviGen’s scientific approach is documented in numerous peer-reviewed scientific publications and validated by its founders’ track record in scientific innovations for the diagnosis and treatment of cardiac diseases, including gene therapy medicinal products. *

 

Period Start 2019-05-22 established (s-off)
  Predecessor University of Heidelberg (Ruperto Carola)
Products Industry gene therapy
  Industry 2 adeno-associated viral vector (AAV vector)
Persons Person Most, Patrick (Aavigen 201905– Managing Director + Inocard 201401– Managing Director + Co-founder)
  Person 2 Lerchenmüller, Marc (AaviGen 202307 Managing Director + CFO + Co-Founder)
     
Region Region Heidelberg
  Country Germany
  Street 410 Im Neuenheimer Feld
  City 69120 Heidelberg
  Tel +49- 6221-56-8900
    Address record changed: 2023-08-24
     
Basic data Employees n. a.
     
    * Document for »About Section«: AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg.
     
   
Record changed: 2023-12-30

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for AaviGen GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top